Latest Breaking News On - Board of directors curis inc - Page 2 : comparemela.com

03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. . Seite 1

Michaelh tardugnoJamese dentzerBoard of directors curis incImunon inc nasdaqValeritas incBiogen incAmicus therapeutics incCuris incDicerna pharmaceuticals incChief executive officerCuri chief operating officerChief financialFrom marchCuri chief administrative officerChief financial officerDicerna pharmaceuticals